These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32738081)

  • 1. PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice.
    McDonough W; Aragon IV; Rich J; Murphy JM; Abou Saleh L; Boyd A; Koloteva A; Richter W
    FASEB J; 2020 Sep; 34(9):12533-12548. PubMed ID: 32738081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cAMP-phosphodiesterase 4 (PDE4) potentiates the anesthetic effects of Isoflurane in mice.
    Aragon IV; Boyd A; Abou Saleh L; Rich J; McDonough W; Koloteva A; Richter W
    Biochem Pharmacol; 2021 Apr; 186():114477. PubMed ID: 33609559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of type 4 cAMP-phosphodiesterases (PDE4s) in mice induces hypothermia via effects on behavioral and central autonomous thermoregulation.
    McDonough W; Rich J; Aragon IV; Abou Saleh L; Boyd A; Richter A; Koloteva A; Richter W
    Biochem Pharmacol; 2020 Oct; 180():114158. PubMed ID: 32702371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
    Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
    Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the therapeutic index of a novel phosphodiesterase 4B-selective inhibitor over phosphodiesterase 4D in mice.
    Suzuki O; Mizukami K; Etori M; Sogawa Y; Takagi N; Tsuchida H; Morimoto K; Goto T; Yoshino T; Mikkaichi T; Hirahara K; Nakamura S; Maeda H
    J Pharmacol Sci; 2013; 123(3):219-26. PubMed ID: 24152964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
    Davis TG; Peterson JJ; Kou JP; Capper-Spudich EA; Ball D; Nials AT; Wiseman J; Solanke YE; Lucas FS; Williamson RA; Ferrari L; Wren P; Knowles RG; Barnette MS; Podolin PL
    J Pharmacol Exp Ther; 2009 Sep; 330(3):922-31. PubMed ID: 19498103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
    Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
    PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species.
    Rutter AR; Poffe A; Cavallini P; Davis TG; Schneck J; Negri M; Vicentini E; Montanari D; Arban R; Gray FA; Davies CH; Wren PB
    J Pharmacol Exp Ther; 2014 Jul; 350(1):153-63. PubMed ID: 24784567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
    Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cAMP-phosphodiesterase 4 (PDE4) controls β-adrenoceptor- and CFTR-dependent saliva secretion in mice.
    Boyd A; Aragon IV; Abou Saleh L; Southers D; Richter W
    Biochem J; 2021 May; 478(10):1891-1906. PubMed ID: 33944911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
    Togo S; Liu X; Wang X; Sugiura H; Kamio K; Kawasaki S; Kobayashi T; Ertl RF; Ahn Y; Holz O; Magnussen H; Fredriksson K; Skold CM; Rennard SI
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L959-69. PubMed ID: 19304913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases.
    Souness JE; Rao S
    Cell Signal; 1997; 9(3-4):227-36. PubMed ID: 9218122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[
    Takano A; Uz T; Garcia-Segovia J; Tsai M; Lahu G; Amini N; Nakao R; Jia Z; Halldin C
    Mol Imaging Biol; 2018 Aug; 20(4):615-622. PubMed ID: 29441434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia.
    Yu MC; Chen JH; Lai CY; Han CY; Ko WC
    Eur J Pharmacol; 2010 Feb; 627(1-3):269-75. PubMed ID: 19853596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDE4 as a target for cognition enhancement.
    Richter W; Menniti FS; Zhang HT; Conti M
    Expert Opin Ther Targets; 2013 Sep; 17(9):1011-27. PubMed ID: 23883342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibition.
    Schepers M; Hendrix S; Mussen F; van Breedam E; Ponsaerts P; Lemmens S; Hellings N; Ricciarelli R; Fedele E; Bruno O; Brullo C; Prickaerts J; Van Broeckhoven J; Vanmierlo T
    Neurotherapeutics; 2024 Jul; 21(4):e00372. PubMed ID: 38760316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
    Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
    J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice.
    Boyd A; Aragon IV; Rich J; McDonough W; Oditt M; Irelan D; Fiedler E; Abou Saleh L; Richter W
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway.
    Robichaud A; Savoie C; Stamatiou PB; Tattersall FD; Chan CC
    Neuropharmacology; 2001; 40(2):262-9. PubMed ID: 11114405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice.
    Zhang FF; Wang H; Zhou YM; Yu HY; Zhang M; Du X; Wang D; Zhang F; Xu Y; Zhang JG; Zhang HT
    CNS Neurosci Ther; 2022 May; 28(5):749-760. PubMed ID: 35156776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.